Steven Cohen's position in Viridian Therapeutics is currently worth $1.94M. That's 0.00% of their equity portfolio (754th largest holding). The first Viridian Therapeutics trade was made in Q1 2021. Since then Steven Cohen bought shares five more times and sold shares on nine occasions. The stake costed the investor $1.78M, netting the investor a gain of 9.2% so far.